AP - A flawed Medicare payment plan encourages aggressive use of a risky and costly anti-anemia drug on many kidney dialysis patients, say researchers who warn the system should be changed.
Source: http://rss.news.yahoo.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment